Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer
Crossref DOI link: https://doi.org/10.1038/pcan.2016.44
Published Online: 2016-09-27
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sonpavde, G
Pond, G R
Templeton, A J
Kwon, E D
De Bono, J S
Text and Data Mining valid from 2016-09-27
Version of Record valid from 2016-09-27
Article History
Received: 13 March 2016
Revised: 27 May 2016
Accepted: 16 June 2016
First Online: 27 September 2016
Competing interests
: The authors declare no conflict of interest.